A multicenter, open label, non-comparative trial investigating the recovering of IFN-beta efficacy in breakthrough relapsing-remitting multiple sclerosis patients with neutralizing IFN-beta antibodies (RECOVER)

J-P Erälinna, Jan Hillert, K-M Myhr, Claus Madsen, Thor Petersen

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalMultiple sclerosis
Volume14
Issue number1 supp.
Pages (from-to)S40
Number of pages1
ISSN1352-4585
Publication statusPublished - 2008
Event24th Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Montreal, Canada
Duration: 24. Aug 2010 → …

Conference

Conference24th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Country/TerritoryCanada
CityMontreal
Period24/08/2010 → …

Cite this